A Study in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 154 participants.

Also called NCT01847092

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 154 participants (enrolled count) (from the registry)
Sponsor
  • Ardelyx Registry lists this organization as the lead sponsor
  • AstraZeneca Registry lists this organization as a collaborator
Registry
  • NCT NCT01847092
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01847092. Randomized; quadruple masking; primary purpose treatment. Start 2013-05 (registry gives no type); primary completion 2015-03 (actual). Results posted on 2020-05-27.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria
Condition
Type 2 Diabetes Mellitus
Intervention (Drug)
AZD1722
Intervention (Drug)
Placebo
Lead sponsor
Ardelyx (class: industry)
Collaborator
AstraZeneca (class: industry)

Record details

Record id
cardio:ct-nct01847092
Content hash
d0de40f6d01d07c8fc23b25c0c9937f510287a862a9954f701b18bdd3e358c37